Carrier F, Chang C Y, Duh J L, Nebert D W, Puga A
Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Biochem Pharmacol. 1994 Nov 1;48(9):1767-78. doi: 10.1016/0006-2952(94)90463-4.
The aromatic hydrocarbon (Ah) receptor complex is a ligand-activated transcriptional activator consisting of at least two protein components. The ligand-binding component is the AhR protein, a cytosolic receptor encoded by the Ahr gene, which, upon ligand binding, translocates to the nucleus in a heterodimeric complex with the ARNT (Ah receptor nuclear translocator) component. The complex binds to several discrete DNA domains containing aromatic hydrocarbon responsive elements (AhRE) present in the regulatory region of the murine cytochrome P(1)450 Cyp1a1 gene and of the other genes in the [Ah] gene battery. As a consequence of binding, a transcriptional complex is formed that activates the expression of these genes by as yet unidentified mechanisms. We have analyzed DNA-protein interactions in four of these domains, specifically, the AhREs located between -1085 and -482 (sites A, C, E, and D) of the upstream regulatory region of the murine Cyp1a1 gene. We found that two DNA-binding proteins, present in cytosolic and nuclear extracts of mouse Hepa-1 cells, showed overlapping DNA-binding specificities to those of the Ah receptor. One of these proteins had an apparent molecular mass of 35-40 kDa, bound only to AhRE3 (site D), and has been identified tentatively as a member of the C/EBP family of transcription factors. The second protein, purified by DNA-affinity chromatography, had an apparent molecular mass of 95 kDa and bound to a larger DNA motif that included the AhRE sequence, in AhRE3 and AhRE5 (sites D and A), but not in AhRE1 or AhRE2 (sites C and E). This protein was not AhR nor was it ARNT, since it was found in receptorless (Ahr-) and in nuclear translocation-defective (Arnt-) cells, as well as in cells that had not been exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; dioxin), a potent inducer of Cyp1a1 expression. Evidence from in vivo methylation protection indicated that two G residues flanking AhRE3, one of which is required for binding of the 95-kDa protein, may be protected from methylation in uninduced cells and become exposed upon dioxin treatment, suggesting that the 95-kDa protein may be constitutively bound to AhRE3, and be displaced by binding of the Ah receptor complex. These results lend support to the concept that the transcriptional regulation of the [Ah] battery genes could be modulated by combinatorial interactions of the Ah receptor complex with other transcription factors.
芳烃(Ah)受体复合物是一种配体激活的转录激活因子,至少由两种蛋白质成分组成。配体结合成分是AhR蛋白,它是由Ahr基因编码的胞质受体,在配体结合后,与ARNT(Ah受体核转运蛋白)成分以异二聚体复合物的形式转运到细胞核中。该复合物与几个离散的DNA结构域结合,这些结构域含有存在于小鼠细胞色素P(1)450 Cyp1a1基因调控区以及[Ah]基因簇中其他基因调控区的芳烃反应元件(AhRE)。结合的结果是形成一个转录复合物,该复合物通过尚未明确的机制激活这些基因的表达。我们分析了其中四个结构域中的DNA-蛋白质相互作用,具体而言,是小鼠Cyp1a1基因上游调控区位于-1085至-482之间的AhRE(位点A、C、E和D)。我们发现,存在于小鼠Hepa-1细胞胞质和核提取物中的两种DNA结合蛋白,对Ah受体的DNA结合特异性具有重叠性。其中一种蛋白的表观分子量为35 - 40 kDa,仅与AhRE3(位点D)结合,初步鉴定为转录因子C/EBP家族的成员。通过DNA亲和层析纯化的第二种蛋白,表观分子量为95 kDa,与一个更大的DNA基序结合,该基序包括AhRE3和AhRE5(位点D和A)中的AhRE序列,但不包括AhRE1或AhRE2(位点C和E)中的序列。这种蛋白既不是AhR也不是ARNT,因为在无受体(Ahr-)和核转运缺陷(Arnt-)细胞中以及未暴露于2,3,7,8-四氯二苯并对二恶英(TCDD;二恶英)(Cyp1a1表达的强效诱导剂)的细胞中都发现了它。体内甲基化保护的证据表明,AhRE3两侧的两个G残基(其中一个是95 kDa蛋白结合所必需的)在未诱导的细胞中可能免受甲基化作用,而在二恶英处理后会暴露出来,这表明95 kDa蛋白可能一直与AhRE3结合,并在Ah受体复合物结合时被取代。这些结果支持了这样一种概念,即[Ah]基因簇基因的转录调控可能通过Ah受体复合物与其他转录因子的组合相互作用来调节。